BioSpace News Archive

Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy to treat severely calcified cardiovascular disease, announced updated timing for the company’s CAD III Investor Webcast Event to be held in conjunction with TCT Connect.

Halberd Corporation announced they have obtained world-wide license to a provisional patent application covering a nasal spray to be used as a prevention measure against coronavirus.

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that management plans to participate in the Jefferies Virtual Cell Therapy Summit in October 2020. Jefferies Virtual Cell Therapy Summit Tuesday, October 6, 2020 12:30 PM PT/3:30 PM ET This webcast will be made available on the Company’s website at w

Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report third quarter 2020 financial results on Wednesday, October 21, 2020, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Company’s website at http://investor.aligntech.com . Following the press release, the Company will host a conference call to discuss it

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune ® T-cell activating technology, today announced their participation in Noble Capital Markets’ Virtual Road Show Series, presented by Channelchek, scheduled for October 6, 2020. The virtual road show will feature a corporate presentation from PDS

BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a fireside chat at the 7 th Annual Jefferies Cell Therapy Virtual Summit on October 5, 2020 at 12:30 pm ET. To access the live webcast presentation, or the subsequent archived recording, please visit the “Investors” section of the Ziopharm website at www.ziopharm.com . About Ziopharm Onco

Quisitive enables leading ophthalmic lens provider to rollout appointment application to help eye care offices safely reopen around the globe

- Evaluating 3 doses of olorinab in study participants with the clinical diagnosis of irritable bowel syndrome with predominant constipation (IBS-C) or diarrhea (IBS-D) - Topline data expected Q1 2021 - Significant unmet need for non-opioid, peripherally acting pain management in gastrointestinal disorders [01-October-2020] SAN DIEGO , Oct. 1, 2020

DexCom, Inc. announced that it plans to release its third quarter 2020 financial results after market close on Tuesday, October 27, 2020.

Radius Health, Inc. announced that the company has successfully sold its second oncology pipeline asset – RAD 140 - to Ellipses Pharma Limited, completing Radius’s divestment of its oncology assets.